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PRISMA-P 2015 Checklist
This checklist has been adapted for use with protocol submissions to Systematic Reviewsfrom 
METHODS

Eligibility criteria 8
Specify the study characteristics (e.g., PICO, study design, setting, time frame) and report characteristics (e.g., years considered, language, publication status) to be used as criteria for eligibility for the review
124-127
Information sources 9 Describe all intended information sources (e.g., electronic databases, contact with study authors, trial registers, or other grey literature sources) with planned dates of coverage
138-161
Search strategy 10 Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be repeated 138-161
STUDY RECORDS
Data management 11a Describe the mechanism(s) that will be used to manage records and data throughout the review 172-180
Selection process 11b State the process that will be used for selecting studies (e.g., two independent reviewers) through each phase of the review (i.e., screening, eligibility, and inclusion in meta-analysis)
163-170
Data collection process 11c Describe planned method of extracting data from reports (e.g., piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators
191-192
Data items 12 List and define all variables for which data will be sought (e.g., PICO items, funding sources), any pre-planned data assumptions and simplifications
183-188
Outcomes and prioritization 13 List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale
186-188
Risk of bias in individual studies 14
Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis inappropriate medication, with an impact on health outcomes in the elderly. The search will 68 be performed during January and February 2018. Two reviewers will conduct articles' 69 screening, selection, and data extraction, independently and blind to each other. Eligible 70 sources will be selected after discussing non-conformities. All extracted data, from the 71 included articles, will be assessed based on studies' participants, design and setting, 72 methodological quality, bias and any other potential sources of heterogeneity. This review 73 will be conducted and reported in adherence with the PRISMA statement of quality for 74 reporting systematic reviews and meta-analyses. 75
76
Ethics and Dissemination: As a systematic review, this research is exempt from ethical 77 approval. We intend to publish the full article in a related peer-reviewed journal and present 78 it at international conferences. 79 In developed countries, aging population is increasing (1). Caring for older adults is a 97 challenge for healthcare providers, as they are more likely to have multi-morbidities (2, 3) 98 and to consume more medication (4). 99
Polypharmacy, defined as "the use of multiple drugs administered to the same patient, most 100 commonly seen in elderly patients"(5, 6), although frequent has a negative impact on senior 101 health (7, 8) . There is an increased risk of drug interactions and prescriptions of potentially 102 inappropriate medications (4), changes in pharmacokinetics and pharmacodynamics and 103 limited generalization of clinical research results due to common exclusion of subjects with 104 more than 65-years-old (9). So, prescribing medication for elderly patients should be 105 evidence-based and particularly cautious. 106
In several cases it is urgent to deprescribe, this is to begin "the process of withdrawal of 107 inappropriate medication, supervised by a health care professional with the goal of 108 managing polypharmacy and improving outcomes" (10). 109
Inappropriate medication prescription, meaning "the practice of administering medications 110 in a manner that poses more risk than benefit, particularly where safer alternatives exist" (5, 111 11), can be reduced by several interventions (12). However, they are not widely known and 112 therefore used. In one hand, general practitioners report interest in learning and using more 113 mobile technologies to assist in clinical care (13) 
Methods and Analysis
130
Eligibility criteria 131
In this systematic review we will select 1) interventional studies, such as RCTs, non-132 randomized controlled studies, and quasi-randomized controlled studies; 2) that include 133 participants with 65 years or more, to whom one or more regular medications were 134 prescribed and 3) assess the impact of computerized decision support systems in 135 withdrawal of potentially inappropriate medication prescription. On the other hand, studies 136 including only moribund, terminal, or palliative participants will be excluded. Studies 137 published or in press will be included independently of the language, year of publication, 138 and setting in which it was conducted (hospitals, nursing centres, communities, etc.). 139
Potentially inappropriate medications will be defined using the Beers Criteria (17) and 140
STOPP/START Criteria (18). 141 142
Information sources 143
Our sources of information will include electronic databases (namely MEDLINE, 144 CENTRAL, EMBASE, Web of Science), trial registries, different types of grey literature, 145
and contact with specialists in the field. If further data is needed, authors of the selected 146 articles will be contacted. The search will be performed in January and February 2018. The 147 search will have no language restrictions. In those cases that none of the research team 148 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r p e e r r e v i e w o n l y making) OR "medical order entry systems" OR (medical AND order entry systems) OR 180 (medications AND alert AND systems) OR "computorized physician order entry systems" 181 OR "computorized provider order entry systems" OR "computorized physician order 182 entry" OR "computorized provider order entry"). 183
184
Study selection process 185
Two authors will independently, and blinded to each other, perform the primary article 186 screening. First, they will review the title and abstract, and categorise the articles into three 187 groups: relevant, irrelevant, and unsure. Articles categorised as irrelevant by both reviewers 188 will be eliminated from the study. Then, each reviewer will review the full text of the 189 remaining articles and make a list of those to be included. For both stages, the two lists will 190 be compared and disagreements will be discussed. When an agreement cannot be reached, 191 the whole team of researchers will come to the final decision. 192
193
Data extraction and management 194
Once the articles to be included are selected, data will be extracted and entered into data 195 sheets independently by two reviewers. These two sheets, including their differences, will 196 be checked by a third reviewer. 197
The following information will be extracted from each article: 1) study characteristics, 198 intervention type; type of study; country, setting, follow-up duration; 2) participants' 199 number and age; and 3) clinical outcomes. The primary outcome to be considered is the 200 effect of intervention on withdrawal of potentially inappropriate medications 201 (discontinuation rate). The authors will give priority to the following outcomes, by order of 202 importance: mortality, hospitalization, any reported adverse drug withdrawal effects, and 203 quality of life measurements. 204
Any potential difference among reviewers will be discussed with the team, and if not 205 resolved, the manuscript authors will be contacted. Also, if required data are missing from 206 the article or are incomplete or unclear, inquiries will similarly be sent to the authors. 207 208 
Data synthesis 213
The final report will present the available data of the computer decision to support in 214 reducing inappropriate medication prescription in older adults. 215 Each outcome will be combined and calculated using the statistical software RevMan 5.1 216 (20), according to statistical guidelines referenced in the current version of the Cochrane 217
Handbook for Systematic Reviews of Interventions (21). 218
If we are able to include a group of studies that are sufficiently comparable and reliable we 219 will conduct a meta-analysis. We consider that we should use a random effect model taking 220 in consideration the previous systematic reviews' results. We expect to encounter a 221 sufficient number of studies, reporting a sufficient number of events, but that are not 222 completely comparable (concerning the intervention, context and population). 223
If heterogeneity is severe (I 2 superior to 40-50%) and studies' results are strongly biased, 224
we will not perform a meta-analysis; thus, a narrative, qualitative summary will be done 225
instead. 226
Effect sizes and 95% confidence intervals (CIs) will be expressed as odds ratios (OR). 227
When a study reports zero events in both arms, we will consider using zero-cell correction 228 methods. 229 Subgroup analyses will be used to explore possible sources of heterogeneity, based on the 230 following: setting, type of software, medication and participants' clinical characteristics. 231
Regarding subgroups, we assume it will be relevant to include subgroups regarding the tool 232 used by software to identify targets: STOPP/START criteria subgroup and the Beers 233 criteria. We will also conduct meta-regression to evaluate whether the covariates have 234 significant influence on heterogeneity. 235 Forest plots will be produced when three or more studies are included in a meta-analysis. 236
Data in tables will be presented by therapeutic class, based on the Anatomical Therapeutic 237 Classification (ATC) codes. 238 Studies rated as having a high risk of bias will be included in the narrative synthesis but not 239 on our meta-analysis and discussed in detail. 240 A systematic narrative synthesis will be provided in the text and tables to summarise and 241 explain the characteristics and findings of the studies; it will explore the relationship within 242 and between studies, in line with guidance from the Centre for Reviews and Dissemination. 243
In order to determine whether publication bias is present, we will include funnel plot and 244 statistical tests in the assessment, namely Begg's and Egger's test. 245
We will also ascertain if each RCT had their protocol published before recruitment of 246 patients was initiated. 247
The quality of evidence for all outcomes will be judged with the Grading of 248
Recommendations Assessment, and the Development and Evaluation working group 249 methodology (22) . 250
The final paper will be prepared following the Preferred Reporting Items for Systematic 251
Reviews and Meta-Analyses (PRISMA) guidelines (23, 24) . 252
253
Ethics and Dissemination
255
As a systematic review, this research is exempt from ethical approval. We intend to publish 256 the full article in a related peer-reviewed journal and present it in international conferences. 257
258
Discussion
260
Although electronic health records are common in clinical practice, there is a lack of 261 evidence of computer decision support systems regarding health outcomes. Deprescribing 262 potentially inappropriate medication in the elderly is particularly difficult, although 263 computer support may be an important tool. This systematic review will help identify the 264 success of computerized decision support to reduce inappropriate medication prescription. 265 Therefore, this review will be relevant for patients, health professionals, and policy makers. 266
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Risk of bias in individual studies 14
Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis [191] [192] 210-211
DATA
Synthesis
15a Describe criteria under which study data will be quantitatively synthesized 195-229 15b If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data, and methods of combining data from studies, including any planned exploration of consistency (e.g., I 2 , Kendall's tau) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46 
